Eastern Pines Conv Ctr | |
29 North Vermont Ave, Atlantic City, New Jersey 08401 | |
(609) 344-8911 | |
Name | Eastern Pines Conv Ctr |
---|---|
Location | 29 North Vermont Ave, Atlantic City, New Jersey |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 151 |
Occupancy Rate | 57.75% |
Medicare ID (CCN) | 315317 |
Legal Business Name | Eastern Pines Llc |
Ownership Type | For Profit - Corporation |
NPI Number | 1437141348 |
Organization Name | EASTERN PINES LLC |
Address | 29 N Vermont Ave, Atlantic City, NJ 08401 |
Phone Number | 609-344-8900 |
News Archive
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
In the presentation, Damian Marron will provide an overview of TxCell and its personalized T cell immunotherapy platform ASTrIA. Additional details will also be provided to institutional investors in one on one meetings at the conference.
Fareed Abdullah, CEO of the South African National AIDS Council (SANAC), who took office in July, spoke with PlusNews regarding the body's reform, the revival of provincial AIDS councils, resource mobilization, and the appointment of a new board that allows SANAC to operate independently.
ERYTECH Pharma, a French biopharmaceutical company that develops innovative treatments for acute leukemia and other oncology indications with unmet medical needs, announces that its lead product GRASPA®/ERY-ASP has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for the treatment of Acute Myeloid Leukemia (AML), an aggressive form of blood cancer.
The European Research Council (ERC) is providing 10 million euros in funding for an interdisciplinary, collaborative project in the structural and biophysical analysis of selected photoreceptors and their development into "OptoGPCRs", light-controlled molecular switches with a wide range of applications in biology and medicine.
› Verified 7 days ago
NPI Number | 1649939638 |
Organization Name | EASTERN PINES CARE AND REHABILITATION CENTER LLC |
Address | 29 N Vermont Ave, Atlantic City, NJ 08401 |
Phone Number | 609-344-8900 |
News Archive
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
In the presentation, Damian Marron will provide an overview of TxCell and its personalized T cell immunotherapy platform ASTrIA. Additional details will also be provided to institutional investors in one on one meetings at the conference.
Fareed Abdullah, CEO of the South African National AIDS Council (SANAC), who took office in July, spoke with PlusNews regarding the body's reform, the revival of provincial AIDS councils, resource mobilization, and the appointment of a new board that allows SANAC to operate independently.
ERYTECH Pharma, a French biopharmaceutical company that develops innovative treatments for acute leukemia and other oncology indications with unmet medical needs, announces that its lead product GRASPA®/ERY-ASP has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for the treatment of Acute Myeloid Leukemia (AML), an aggressive form of blood cancer.
The European Research Council (ERC) is providing 10 million euros in funding for an interdisciplinary, collaborative project in the structural and biophysical analysis of selected photoreceptors and their development into "OptoGPCRs", light-controlled molecular switches with a wide range of applications in biology and medicine.
› Verified 7 days ago
NPI Number | 1699553446 |
Organization Name | EASTERN PINES CARE AND REHABILITATION CENTER LLC |
Address | 29 N Vermont Ave, Atlantic City, NJ 08401 |
Phone Number | 609-344-8900 |
News Archive
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
In the presentation, Damian Marron will provide an overview of TxCell and its personalized T cell immunotherapy platform ASTrIA. Additional details will also be provided to institutional investors in one on one meetings at the conference.
Fareed Abdullah, CEO of the South African National AIDS Council (SANAC), who took office in July, spoke with PlusNews regarding the body's reform, the revival of provincial AIDS councils, resource mobilization, and the appointment of a new board that allows SANAC to operate independently.
ERYTECH Pharma, a French biopharmaceutical company that develops innovative treatments for acute leukemia and other oncology indications with unmet medical needs, announces that its lead product GRASPA®/ERY-ASP has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for the treatment of Acute Myeloid Leukemia (AML), an aggressive form of blood cancer.
The European Research Council (ERC) is providing 10 million euros in funding for an interdisciplinary, collaborative project in the structural and biophysical analysis of selected photoreceptors and their development into "OptoGPCRs", light-controlled molecular switches with a wide range of applications in biology and medicine.
› Verified 7 days ago
NPI Number | 1710256177 |
Organization Name | EASTERN PINES LLC |
Doing Business As | EASTERN PINES VENT UNIT |
Address | 29 N Vermont Ave, Atlantic City, NJ 08401 |
Phone Number | 609-344-8900 |
News Archive
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
In the presentation, Damian Marron will provide an overview of TxCell and its personalized T cell immunotherapy platform ASTrIA. Additional details will also be provided to institutional investors in one on one meetings at the conference.
Fareed Abdullah, CEO of the South African National AIDS Council (SANAC), who took office in July, spoke with PlusNews regarding the body's reform, the revival of provincial AIDS councils, resource mobilization, and the appointment of a new board that allows SANAC to operate independently.
ERYTECH Pharma, a French biopharmaceutical company that develops innovative treatments for acute leukemia and other oncology indications with unmet medical needs, announces that its lead product GRASPA®/ERY-ASP has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for the treatment of Acute Myeloid Leukemia (AML), an aggressive form of blood cancer.
The European Research Council (ERC) is providing 10 million euros in funding for an interdisciplinary, collaborative project in the structural and biophysical analysis of selected photoreceptors and their development into "OptoGPCRs", light-controlled molecular switches with a wide range of applications in biology and medicine.
› Verified 7 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
In the presentation, Damian Marron will provide an overview of TxCell and its personalized T cell immunotherapy platform ASTrIA. Additional details will also be provided to institutional investors in one on one meetings at the conference.
Fareed Abdullah, CEO of the South African National AIDS Council (SANAC), who took office in July, spoke with PlusNews regarding the body's reform, the revival of provincial AIDS councils, resource mobilization, and the appointment of a new board that allows SANAC to operate independently.
ERYTECH Pharma, a French biopharmaceutical company that develops innovative treatments for acute leukemia and other oncology indications with unmet medical needs, announces that its lead product GRASPA®/ERY-ASP has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for the treatment of Acute Myeloid Leukemia (AML), an aggressive form of blood cancer.
The European Research Council (ERC) is providing 10 million euros in funding for an interdisciplinary, collaborative project in the structural and biophysical analysis of selected photoreceptors and their development into "OptoGPCRs", light-controlled molecular switches with a wide range of applications in biology and medicine.
› Verified 7 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 7.97 | 14.46 |
Percentage of long-stay residents who lose too much weight | 6.85 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 21.7 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.27 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 1.51 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 3.29 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 0 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 7.27 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 97.85 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 19.95 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 22.53 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 17.02 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 97.76 | 95.98 |
Percentage of short-stay residents who made improvements in function | 85.23 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 97.93 | 82.93 |
News Archive
Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
In the presentation, Damian Marron will provide an overview of TxCell and its personalized T cell immunotherapy platform ASTrIA. Additional details will also be provided to institutional investors in one on one meetings at the conference.
Fareed Abdullah, CEO of the South African National AIDS Council (SANAC), who took office in July, spoke with PlusNews regarding the body's reform, the revival of provincial AIDS councils, resource mobilization, and the appointment of a new board that allows SANAC to operate independently.
ERYTECH Pharma, a French biopharmaceutical company that develops innovative treatments for acute leukemia and other oncology indications with unmet medical needs, announces that its lead product GRASPA®/ERY-ASP has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for the treatment of Acute Myeloid Leukemia (AML), an aggressive form of blood cancer.
The European Research Council (ERC) is providing 10 million euros in funding for an interdisciplinary, collaborative project in the structural and biophysical analysis of selected photoreceptors and their development into "OptoGPCRs", light-controlled molecular switches with a wide range of applications in biology and medicine.
› Verified 7 days ago
Eastern Pines Conv Ctr Location: 29 North Vermont Ave, Atlantic City, New Jersey 08401 Phone: (609) 344-8911 |